Health Care & Life Sciences » Pharmaceuticals » Biotechnology industry | Biotech alliances by up-front payments U.S. and Europe 2016

Alliances in U.S. and Europe biotechnology industry with big up-front payments 2016

Biotech alliances with big up-front payments in the U.S. and Europe in 2016 (Figures expressed in millions of U.S. dollars, unless otherwise specified)

The data illustrates alliances formed in the U.S. and the European biotechnology industry with large up-front payments in 2016. During this year, Japanese company Otsuka had an alliance with U.S. company Akebia Therapeutics and delivered an up-front payment of 265 million USD.

Otsuka Pharmaceutical (Akebia Therapeutics) 265
Celgene (Jounce Therapeutics) 261
Teva (Regeneron Therapeutics) 250
Celgene (Agios Therapeutics) 200
Incyte (Merus) 200
Merck & Co. (ModeRNA) 200
Baxalta (Symphogen) 175
Novartis (Xencor) 150
Allergan (Heptares Therapeutics) 125
Regeneron Pharmaceuticals (IntelliaTherapeutics) 125

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.